Pharmaceutical Opioids For Chronic Non-cancer Pain: Evaluating Health Outcomes And Economic Impact Over Five Years
Funder
National Health and Medical Research Council
Funding Amount
$775,922.00
Summary
Chronic non-cancer pain (CNCP) is a major contributor to disability. Increased opioid prescribing for CNCP has produced concern about dependence and overdose in the absence on data on its long-term effectiveness. Novel statistical methods will test causal relationships over 5 years between treatment, outcomes, and costs on 1,514 CNCP patients prescribed opioids. We will answer critical questions on 5-year outcomes, and whether, and for whom, opioids and other clinical interventions reduce costs.
Using Big Data To Reduce Inappropriate Medication Use
Funder
National Health and Medical Research Council
Funding Amount
$318,768.00
Summary
Potentially inappropriate medication use both increases patient harm and wastes considerable health resources. However methods for measuring patterns of use are not well developed nor utilised in policy. This research will measure the scope, variation and burden of potentially inappropriate medication use in Australia. My unique combination of biostatistical, data and policy expertise will enable this research to create new actionable tools for evaluating the Australian healthcare system.
Creating Sustainable Healthcare: Ensuring New Diagnostics Avoid Harms, Improve Outcomes, And Direct Resources Wisely
Funder
National Health and Medical Research Council
Funding Amount
$2,497,658.00
Summary
Novel imaging, biomarkers and genomic tests for risk assessment and early detection are emerging as major forces for change in clinical practice. While providing advances and new benefits for patients, new technologies can also have harmful, unintended consequences - overdiagnosis and overtreatment. This multidisciplinary CRE will investigate how to respond to emerging technologies to optimise health outcomes while avoiding harms and directing healthcare resources wisely.
Optimising Care For Patients Diagnosed With Pancreatic Cancer: A Prospective Cohort Study
Funder
National Health and Medical Research Council
Funding Amount
$1,399,839.00
Summary
There is evidence from previous research in Queensland and NSW that elements of care provided to patients with pancreatic cancer are sub-optimal. We aim to improve compliance with evidence-based guidelines in Victoria and NSW by collecting high quality data, providing reports to hospitals benchmarking their performance against peers and working with health services to reduce variation. Making sure care known to improve practice is being delivered is as important as developing new targeted thera
Preventing Hospital Readmission In A Regional Australian Hospital Setting
Funder
National Health and Medical Research Council
Funding Amount
$565,695.00
Summary
Hospitals face high levels of emergency presentations and demand for inpatient care particularly for Aboriginal Australian people from remote communities. Readmissions lead to overcrowded emergency departments and poorer patient outcomes. We will evaluate the efficacy of a multidimensional case-based management intervention linking hospital and primary health in a regional Australian hospital with the aim of reducing hospital readmission and improving patient outcomes.
Sydney Epilepsy Incidence Study To Measure Illness Consequences (SEISMIC)
Funder
National Health and Medical Research Council
Funding Amount
$694,067.00
Summary
Epilepsy is common, costly and neglected. This study is a prospective cohort study of newly diagnosed cases of epilepsy and aims to fill clinical, psychosocial and economic knowledge gaps in epilepsy. The network will use this new evidence for policy recommendations and strategic plans, for health systems and guidelines to improve efficiency and care and to enlighten community-based support programs, education, driving and workplace legislation. This study was developed by a health service, Epil ....Epilepsy is common, costly and neglected. This study is a prospective cohort study of newly diagnosed cases of epilepsy and aims to fill clinical, psychosocial and economic knowledge gaps in epilepsy. The network will use this new evidence for policy recommendations and strategic plans, for health systems and guidelines to improve efficiency and care and to enlighten community-based support programs, education, driving and workplace legislation. This study was developed by a health service, Epilepsy Action, Epilepsy Society of Australia and the George Institute.Read moreRead less